Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Assets Average (2016 - 2025)

Historic Assets Average for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to $8.8 million.

  • Pharma's Assets Average fell 1563.23% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year decrease of 1563.23%. This contributed to the annual value of $9.3 million for FY2025, which is 3113.37% down from last year.
  • Per Pharma's latest filing, its Assets Average stood at $8.8 million for Q3 2025, which was down 1563.23% from $8.3 million recorded in Q2 2025.
  • In the past 5 years, Pharma's Assets Average ranged from a high of $35.2 million in Q2 2021 and a low of $8.3 million during Q2 2025
  • Moreover, its 5-year median value for Assets Average was $16.4 million (2023), whereas its average is $19.1 million.
  • In the last 5 years, Pharma's Assets Average skyrocketed by 2893.54% in 2021 and then tumbled by 4318.89% in 2024.
  • Pharma's Assets Average (Quarter) stood at $32.6 million in 2021, then plummeted by 35.46% to $21.0 million in 2022, then plummeted by 33.94% to $13.9 million in 2023, then fell by 29.96% to $9.7 million in 2024, then decreased by 9.06% to $8.8 million in 2025.
  • Its Assets Average stands at $8.8 million for Q3 2025, versus $8.3 million for Q2 2025 and $8.9 million for Q1 2025.